CARDIOMYOPATHY, HYPERTROPHIC
Clinical trials for CARDIOMYOPATHY, HYPERTROPHIC explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, HYPERTROPHIC trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, HYPERTROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for teens with rare heart condition as drug trial targets obstruction
Disease control OngoingThis study tests a drug called mavacamten in 44 teenagers (ages 12 to under 18) who have a type of heart disease called obstructive hypertrophic cardiomyopathy, where the heart muscle is too thick and blocks blood flow. The goal is to see if the drug can reduce the blockage and i…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 17, 2026 03:30 UTC
-
Heart procedure may beat drugs for deadly rhythm disorder
Disease control OngoingThis study compares two treatments for ventricular tachycardia (VT), a fast heart rhythm that can be life-threatening, in people with structural heart disease. About 162 participants will either get a catheter ablation (a procedure to destroy the tiny area causing the problem) or…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
Heart drug mavacamten shows promise in thickened heart muscle study
Disease control OngoingThis study looks at whether the drug mavacamten can improve heart structure in 63 adults with a condition that makes the heart muscle too thick and blocks blood flow. Participants take the medication and have heart scans to measure changes. The goal is to see if the drug can redu…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:53 UTC